§ 124.201A — Cannabis-derived products — rules

Iowa § 124.201A

• Jurisdiction: Iowa
• Title IV: PUBLIC HEALTH
• Ch. 124: CONTROLLED SUBSTANCES

Text

1. If a cannabis-derived investigational product approved as a prescription drug
medication by the United States food and drug administration is added to the federal
schedule of controlled substances by the federal drug enforcement administration and
notice of the addition is given to the board, the board shall similarly add the prescription
drug medication in the schedule of controlled substances under this chapter.
2. Ifacannabis-derivedproductapprovedasaprescriptiondrugmedicationbytheUnited
States food and drug administration is eliminated from or revised in the federal schedule
of controlled substances by the federal drug enforcement administration and notice of the
elimination or revision is given to the board, the board shall similarly eliminate or revise the
prescription drug medication in the schedule of controlled substances under this chapter.
3. The board shall adopt rules pursuant to chapter 17A to administer this section. The
board may adopt rules on an emergency basis as provided in section 17A.4, subsection 3,
and section 17A.5, subsection 2, to administer this section, and the rules shall be effective
immediately upon filing unless a later date is specified in the rules. Any emergency rules

adopted in accordance with this section shall also be published as a notice of intended action
as provided in section 17A.4, subsection 1.
4. Any cannabis-derived investigational product or cannabis-derived product approved
as a prescription drug medication by the United States food and drug administration shall
not be considered marijuana or cannabimimetic agents, both as defined in section 124.204,
tetrahydrocannabinols as used in section 124.204, subsection 4, paragraph “u”, unnumbered
paragraph 1, or hemp as defined in section 204A.2.

Legislative History

[C73, 75, 77, 79, 81, §204.202]